Wednesday 13th October 2021
|Text too small?|
NorthWest Healthcare Properties Management Limited (the Manager), as manager of Vital Healthcare Property Trust (Vital), today announced the acquisition of The Tennyson Centre, and the intention to raise approximately $140m of new equity capital, through a $115m underwritten placement of new units (the Placement) and a ~$25m Unit Purchase Plan (UPP) (the Offer).
The net proceeds of the Offer provide Vital funding capacity to continue to support its acquisition and development pipeline.
Tennyson Centre acquisition
The Tennyson Centre is one of Adelaide's leading “Cancer Centres of Excellence”, comprising high quality tenants who operate within the identification, assessment and treatment of cancer through oncology, radiotherapy, imaging and consulting services.
The acquisition of Tennyson Centre is aligned with Vital's 5-year portfolio strategy:
• Supports AFFO target growth of 2-3% per annum
• Increases investment allocation to ambulatory care
• Further enhances tenant diversification
• Creates new or expanded relationships with a number of leading national providers of allied health services.
The $115m Placement will be conducted during the course of today, with new units issued at a fixed price of $2.90 per unit, representing a 3.7% discount to the closing price of $3.01 on 12 October 2021. NorthWest has committed to participate in the Placement by subscribing for at least $37.4m of new units, representing its pro rata 26.7% stake in Vital.
The UPP will allow all eligible unitholders with a registered address in New Zealand on the record date to apply for up to $15,000 of new units in Vital. The issue price of the new units under the UPP will be the lower of the Placement price and a 2.5% discount to the volume weighted average price of Vital units traded on the NZX during the five trading days up to, and including, the end of the UPP offer period.
The Offer has been structured to be as fair as possible to all existing unitholders, and enables almost all unitholders to participate through either the Placement or the UPP (except where restricted due to legal constraints), and should scaling be required, it will be by reference to existing unitholdings on the record date.
The UPP offer opens on 19 October 2021, with the offer document and application form also being available from that date.
The new units issued under the Offer will rank equally with existing Vital units on issue and will be eligible for the FY22 first quarter distribution payable in December.
The Placement is underwritten by Forsyth Barr Group Limited and Goldman Sachs New Zealand Limited.
The Board reconfirms Vital’s previously released distribution guidance of 9.50 cents per unit for the FY22 financial year, on a conservative pay-out ratio.
Please see the links below for details
No comments yet
New Zealand Rural Land Company Limited (NZX: NZL) Agreement to acquire large scale dairy asset portfolio
EROAD Limited (NZX: ERD) launches Clarity Solo Dashcam
22nd October 2021 Morning Report
Pictor ready to roll out game-changing COVID antibody test in New Zealand
Scott Technology Limited (NZX: SCT) Announces FY21 Results
21st October 2021 Morning Report
Greenfern Industries Limited (NZX: GFI) L&Q Notice
TruScreen Group Limited (NZX: TRU) Clinical Trial Results Highlight Efficacy of TRU Technology
20th October 2021 Morning Report
Freightways Limited (NZX: FRE) Acquisition of ProducePronto